Annelies Boven (A G Boven)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Antimicrobial Resistance

Clostridium Difficile

Drug Administration

Top Venues

Open forum infectious diseases

Pathogens (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Peace Mpakaniye, Annelies Boven, Steven Callens, Lars Engstrand, Erika Vlieghe, Nele Brusselaers
Clostridioides difficile recurrence in individuals with and without cancer: a Swedish population-based cohort study. Infection 52 (2) (2024)
Peace Mpakaniye, Annelies Boven, Steven Callens, Lars Engstrand, Erika Vlieghe, Nele Brusselaers
Clostridioides difficile recurrence in individuals with and without cancer: a Swedish population-based cohort study. Infection 52 (2) (2024)
Peace Mpakaniye, Annelies Boven, Steven Callens, Lars Engstrand, Erika Vlieghe, Nele Brusselaers
Clostridioides difficile recurrence in individuals with and without cancer: a Swedish population-based cohort study. Infection 52 (2) (2024)
Peace Mpakaniye, Annelies Boven, Steven Callens, Lars Engstrand, Erika Vlieghe, Nele Brusselaers
Clostridioides difficile recurrence in individuals with and without cancer: a Swedish population-based cohort study. Infection 52 (2) (2024)
Peace Mpakaniye, Annelies Boven, Steven Callens, Lars Engstrand, Erika Vlieghe, Nele Brusselaers
Clostridioides difficile recurrence in individuals with and without cancer: a Swedish population-based cohort study. Infection (2024)
Alfred Dusabimana, Joseph Nelson Fodjo Siewe, Michel Mandro Ndahura, Bruno P Mmbando, Stephen Raimon Jada, Annelies Boven, Eric De Smet, Tony Ukety, Alfred Kongnyu Njamnshi, Anne Laudisoit, Steven Abrams, Robert Colebunders
Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6-10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11 , 281. Pathogens (Basel, Switzerland) 11 (7) (2022)
Annelies Boven, Chris Richard Kenyon, Robert Colebunders
Ivermectin Should Not Be Recommended to Treat Severe Acute Respiratory Syndrome 2 Infection. Open forum infectious diseases 8 (12) (2021)